 5-HT2 receptor antagonists have long been known, but recently 5-HT2 receptor agonists are becoming promising agents in the development for new antipsychotic drugs.Historically, most pharmacological research on antipsychotic drugs have concentrated on the 5-HT2A receptor subtype.However, recent studies show that agonist activity on 5-HT2A receptors can cause hallucination.